Novo Nordisk initiates its share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009.

Since the announcement as of 28 September 2009, the following transactions have been made under the programme:

Number of Average Transaction shares purchase price value, DKK Accumulated, last announcement 2,682,500 853,849,597 28 September 2009 70,000 320.8900 22,462,300 29 September 2009 59,500 321.9410 19,155,490 30 September 2009 75,000 318.8990 23,917,425 1 October 2009 75,000 317.6710 23,825,325 2 October 2009 70,000 319.9301 22,395,107 Accumulated under the programme 3,032,000 965,605,244

With the transactions stated above, Novo Nordisk owns a total of 27,868,808 treasury shares, corresponding to 4.5% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.


In the company announcement as of 28 September 2009 related to the share repurchase programme, the dates in the table were not updated properly. All numbers and ownership figures were however correct.


Novo Nordisk A/S



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
New research program receives DKK 100 million in funding from Novo Nordisk Foundation